Annual Current Liabilities
$9.94 M
+$4.64 M+87.59%
31 December 2022
Summary:
Navidea Biopharmaceuticals annual total current liabilities is currently $9.94 million, with the most recent change of +$4.64 million (+87.59%) on 31 December 2022. During the last 3 years, it has risen by +$5.23 million (+110.85%). NAVB annual current liabilities is now -85.77% below its all-time high of $69.86 million, reached on 31 December 2016.NAVB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$7.98 M
-$327.30 K-3.94%
30 September 2023
Summary:
Navidea Biopharmaceuticals quarterly total current liabilities is currently $7.98 million, with the most recent change of -$327.30 thousand (-3.94%) on 30 September 2023. NAVB quarterly current liabilities is now -88.58% below its all-time high of $69.86 million, reached on 31 December 2016.NAVB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAVB Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +110.8% | +94.8% |
| 5 y5 years | +194.3% | +123.1% |
NAVB Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +110.8% | -19.8% | +94.8% |
| 5 y | 5 years | at high | +194.3% | -19.8% | +123.1% |
| alltime | all time | -85.8% | +1557.0% | -88.6% | +1894.7% |
Navidea Biopharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $7.98 M(-3.9%) |
| June 2023 | - | $8.31 M(-10.2%) |
| Mar 2023 | - | $9.25 M(-7.0%) |
| Dec 2022 | $9.94 M(+87.6%) | $9.94 M(+17.9%) |
| Sept 2022 | - | $8.43 M(+58.5%) |
| June 2022 | - | $5.32 M(+8.6%) |
| Mar 2022 | - | $4.90 M(-7.5%) |
| Dec 2021 | $5.30 M(+12.4%) | $5.30 M(+29.4%) |
| Sept 2021 | - | $4.10 M(+1.8%) |
| June 2021 | - | $4.02 M(-3.2%) |
| Mar 2021 | - | $4.16 M(-11.8%) |
| Dec 2020 | $4.72 M(+23.4%) | $4.72 M(+17.5%) |
| Sept 2020 | - | $4.01 M(-3.2%) |
| June 2020 | - | $4.15 M(-4.8%) |
| Mar 2020 | - | $4.35 M(+14.0%) |
| Dec 2019 | $3.82 M(+13.1%) | $3.82 M(+6.8%) |
| Sept 2019 | - | $3.58 M(-6.4%) |
| June 2019 | - | $3.82 M(+11.9%) |
| Mar 2019 | - | $3.42 M(+1.1%) |
| Dec 2018 | $3.38 M(-58.1%) | $3.38 M(-42.2%) |
| Sept 2018 | - | $5.85 M(+26.3%) |
| June 2018 | - | $4.63 M(-61.5%) |
| Mar 2018 | - | $12.03 M(+49.2%) |
| Dec 2017 | $8.07 M(-88.5%) | $8.07 M(+37.1%) |
| Sept 2017 | - | $5.88 M(-25.5%) |
| June 2017 | - | $7.89 M(-20.9%) |
| Mar 2017 | - | $9.98 M(-85.7%) |
| Dec 2016 | $69.86 M(+1029.8%) | $69.86 M(+9.6%) |
| Sept 2016 | - | $63.76 M(+2.2%) |
| June 2016 | - | $62.39 M(+9.3%) |
| Mar 2016 | - | $57.09 M(+823.3%) |
| Dec 2015 | $6.18 M(-31.7%) | $6.18 M(-0.9%) |
| Sept 2015 | - | $6.24 M(+11.6%) |
| June 2015 | - | $5.59 M(-56.7%) |
| Mar 2015 | - | $12.90 M(+42.3%) |
| Dec 2014 | $9.06 M(-19.8%) | $9.06 M(+8.7%) |
| Sept 2014 | - | $8.33 M(+35.5%) |
| June 2014 | - | $6.15 M(+13.0%) |
| Mar 2014 | - | $5.45 M(-51.8%) |
| Dec 2013 | $11.29 M(+82.4%) | $11.29 M(+79.1%) |
| Sept 2013 | - | $6.31 M(+33.6%) |
| June 2013 | - | $4.72 M(-19.0%) |
| Mar 2013 | - | $5.83 M(-5.9%) |
| Dec 2012 | $6.19 M(+84.9%) | $6.19 M(-11.7%) |
| Sept 2012 | - | $7.01 M(+25.1%) |
| June 2012 | - | $5.60 M(+13.9%) |
| Mar 2012 | - | $4.92 M(+46.9%) |
| Dec 2011 | $3.35 M(-15.1%) | $3.35 M(-19.9%) |
| Sept 2011 | - | $4.18 M(-16.2%) |
| June 2011 | - | $4.99 M(+12.6%) |
| Mar 2011 | - | $4.43 M(+12.3%) |
| Dec 2010 | $3.94 M(+64.2%) | $3.94 M(+1.9%) |
| Sept 2010 | - | $3.87 M(+27.8%) |
| June 2010 | - | $3.03 M(-11.5%) |
| Mar 2010 | - | $3.42 M(+42.4%) |
| Dec 2009 | $2.40 M(+3.4%) | $2.40 M(-3.2%) |
| Sept 2009 | - | $2.48 M(+18.0%) |
| June 2009 | - | $2.10 M(-6.1%) |
| Mar 2009 | - | $2.24 M(-3.5%) |
| Dec 2008 | $2.32 M | $2.32 M(+9.8%) |
| Sept 2008 | - | $2.12 M(+25.6%) |
| June 2008 | - | $1.68 M(-8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $1.84 M(-15.4%) |
| Dec 2007 | $2.17 M(-36.3%) | $2.17 M(-63.4%) |
| Sept 2007 | - | $5.93 M(+30.8%) |
| June 2007 | - | $4.53 M(-5.0%) |
| Mar 2007 | - | $4.77 M(+39.8%) |
| Dec 2006 | $3.41 M(+127.0%) | $3.41 M(+229.5%) |
| Sept 2006 | - | $1.03 M(+15.3%) |
| June 2006 | - | $897.80 K(-23.5%) |
| Mar 2006 | - | $1.17 M(-21.9%) |
| Dec 2005 | $1.50 M(+48.7%) | $1.50 M(+47.1%) |
| Sept 2005 | - | $1.02 M(-18.5%) |
| June 2005 | - | $1.25 M(+19.7%) |
| Mar 2005 | - | $1.05 M(+3.7%) |
| Dec 2004 | $1.01 M(-34.5%) | $1.01 M(+12.6%) |
| Sept 2004 | - | $897.10 K(-24.5%) |
| June 2004 | - | $1.19 M(-15.1%) |
| Mar 2004 | - | $1.40 M(-9.2%) |
| Dec 2003 | $1.54 M(-21.0%) | $1.54 M(-47.1%) |
| Sept 2003 | - | $2.91 M(+14.7%) |
| June 2003 | - | $2.54 M(+30.6%) |
| Mar 2003 | - | $1.94 M(-0.3%) |
| Dec 2002 | $1.95 M(-21.2%) | $1.95 M(-48.4%) |
| Sept 2002 | - | $3.78 M(+20.4%) |
| June 2002 | - | $3.14 M(+49.4%) |
| Mar 2002 | - | $2.10 M(-15.1%) |
| Dec 2001 | $2.48 M(+4.3%) | $2.48 M(-2.4%) |
| Sept 2001 | - | $2.54 M(+25.4%) |
| June 2001 | - | $2.02 M(+3.4%) |
| Mar 2001 | - | $1.96 M(-17.5%) |
| Dec 2000 | $2.37 M(-61.4%) | $2.37 M(+30.1%) |
| Sept 2000 | - | $1.82 M(-36.9%) |
| June 2000 | - | $2.89 M(+10.1%) |
| Mar 2000 | - | $2.63 M(-49.5%) |
| Dec 1999 | $6.15 M(-12.3%) | - |
| June 1999 | - | $5.20 M(-5.5%) |
| Mar 1999 | - | $5.50 M(-21.6%) |
| Dec 1998 | $7.01 M(+0.9%) | $7.01 M(+71.0%) |
| Sept 1998 | - | $4.10 M(-14.6%) |
| June 1998 | - | $4.80 M(-21.3%) |
| Mar 1998 | - | $6.10 M(-12.2%) |
| Dec 1997 | $6.95 M(-8.6%) | $6.95 M(-9.7%) |
| Sept 1997 | - | $7.70 M(+6.9%) |
| June 1997 | - | $7.20 M(+41.2%) |
| Mar 1997 | - | $5.10 M(-32.9%) |
| Dec 1996 | $7.60 M(+162.1%) | $7.60 M(+111.1%) |
| Sept 1996 | - | $3.60 M(+44.0%) |
| June 1996 | - | $2.50 M(+13.6%) |
| Mar 1996 | - | $2.20 M(-24.1%) |
| Dec 1995 | $2.90 M(0.0%) | $2.90 M(+52.6%) |
| Sept 1995 | - | $1.90 M(+11.8%) |
| June 1995 | - | $1.70 M(-10.5%) |
| Mar 1995 | - | $1.90 M(-34.5%) |
| Dec 1994 | $2.90 M(+81.3%) | $2.90 M(+61.1%) |
| Sept 1994 | - | $1.80 M(+50.0%) |
| June 1994 | - | $1.20 M(-33.3%) |
| Mar 1994 | - | $1.80 M(+12.5%) |
| Dec 1993 | $1.60 M(+166.7%) | $1.60 M(+23.1%) |
| Sept 1993 | - | $1.30 M(+85.7%) |
| June 1993 | - | $700.00 K(+16.7%) |
| Mar 1993 | - | $600.00 K(0.0%) |
| Dec 1992 | $600.00 K | $600.00 K(+50.0%) |
| Sept 1992 | - | $400.00 K |
FAQ
- What is Navidea Biopharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual total current liabilities?
The current annual current liabilities of NAVB is $9.94 M
What is the all time high annual current liabilities for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual total current liabilities is $69.86 M
What is Navidea Biopharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of NAVB is $7.98 M
What is the all time high quarterly current liabilities for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly total current liabilities is $69.86 M